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  Lifestyle changes to consumption of variegated instant food may be associated several 
heath hazards, such as obesity, dyslipidemia, and atheroschlerosis. This study was conducted to   
investigate the effects of orally administered Sardinella longiceps oil as an anti inflammatory 
agent on the serum levels of  TNF-α and IL-6 considered as biomarkers for atherosclerosis.  
 The study design is an true experimental with randomized pretest and posttest control 
group design, using 50 Wistar rat equaly divided into 5 groups, i.e. placebo control group 0% 
and 4 treatment  groups each treated daily with 10%, 15 %, 20 % and 25 %  fish oil respectively 
for 6 weeks. Before the treatment was started, all rats were orally fed daily with a high 
cholesterol diet for 13 weeks to induce atherosclerosis. Our study showed that the intake of 20% 
fish oil had resulted in the significantly greatest decrease of 45,63 % in the TNF-α serum 
levels,from 28.62 ± 1.25 to 15.56 ± 7.20 рg/mL and similar significant  decrease 15,42% in of 
IL-6 serum levels from 134.64 ± 1.98 to 113.87 ± 4.30 рg/mL. The overall results of our study 
seemed to imply than in the Wistar rats, oral intake of Sardfinella longiceps oils signifacantly 
decreased serum levels of  TNF-α and IL-6 probably through  their anti-inflamatory effects. 
Futher research to determin the magnitude  of effects sardinella longiceps oils on the serum 
levels TNF-α and IL-6  human.  
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It has been understood that there is a significance correlation between high lipid serum 
levels and incidens of atherosclerosis, a trigger of coronary heart desease. Coronary heart 
desease present as a results of blood circulation disturbance and abnormality of cardiac 
electricity or other forms of arythmia. This leads to unorganized myocardiac contraction, blood 
flow obstruction, and blood flow regugirtation. All of these conditions resulted in blood flow on 
each contraction will return back to the heart (shunts), blood flow abnormality and end up with 
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heart failure (Vinay, et al. 2004). Atherosclerosis is a slow rate progressive desease, present in 
large to medium arterial muscle and elastic artery. The main sites of atheroschlerosis are 
abdominal aorta, coronary arteri, poplitea arteri, torax aorta desendens , carotic intern artery, and 
circular Willisi. Risk factors, such as hypertension, chronic hypercholesterolemia, immune 
system disturbance, toxin and virus are also involved in the arterial endotelial wall destruction. 
This demage induces permeability changes of endotelial cells and leads to increase of plasma 
constituen, such as lipoprotein that can easily enter to arteri wall. Demaging of these endotelial 
cells could also changed  thrombosistein lumen artery property that can leads to adhesion of 
thrombosite to the blood and induce inflammation. If this demaging process exeed continually 
for long time, will be followed by continous atheroschlerosis and leads to thickness of tunica 
intima and results in desturbance of blood flow on that site (Szmitko, et al., 2003). Managing 
consumption type is one way to overcome this condition. Decrease of plasma cholesterol can be 
increased by rising of cholesterol turnover rate. Faster cholesterol replacement can be achieved 
through intake of polyunsaturated fatty acids. These acids in metabolism act as an antioxidant 
that could breakdown saturated fatty acid chain of hypercholesterolemia patients (Kanjwal, 
2004). 
Hypercholesterolemia, atherosclerosis inducer is a multifactorial deasase also correlates 
to proinflammatory cytokine, such as IFN-γ, IL-1β, IL-6 and TNF-α. Some research reported 
that atherogenic consumption could increase formation of IL-6 and TNF-α, however, did not 
significantly changes of increase IL-1β (Stefan, et al., 1996; Ahmed ,2001; Han et al., 2002). 
 Based on background explained above, this research was conducted to investigate role of 
Sardinella longiceps oil as an anti inflamation through decrease of IL-6 and TNF-α levels on 
atherosclerosis Wistar rat. 
 
MATERIALS AND METHOD 
 This research is applying a true experimental randomized pre and posttest control group 
design to determine the role of Sardinella longiceps oil for anti inflammation. Research was 
conducted using 50 Wistar rat and grouped into 5 groups, i.e. P0 for control with 0% fish oil, P1 
for treatment with 10% fish oil, P2 for treatment with 15% fish oil, P3 for treatment of 20%, and 
P4 for treatment of 25%. Rats were fed with a high cholesterol diet for 13 weeks to achieved 
atheroschlerosis, then was treated with various concentration of fish oil for 6 weeks. TNF-α and 
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IL-6 levels rats serum for atheroschlerosis (pretest) and after treated (posttest) were then 
detected. All data obtained were analyzed statistically to determine the mean different of 
treatment using one way anova at 5% significant level.  
 
RESULTS 
Decrease of TNF-α levels  
 Mean of TNF-α serum levels pre and postest data were presented in Table 1.  
Table 1 
Mean of TNF-α serum levels data 
 
Treatment TNF-α ( pg /mL) Pretest Postest 
SFO   0 % (control) 28.98 ± 6.00  28.11 ± 5.94   
SFO 10 % 29.12 ± 5.79  27.32 ± 5.01    
SFO 15 % 29.02 ± 5.34  24.42 ± 5.74     
SFO 20 % 28.62 ± 4.72  15.56 ± 7.20     
SFO 25 % 29.02 ± 5.06  26.02 ± 8.34     
                                            SFO = Sardinella longiceps fish oil 
 Data on Table 1 were normally distributed with p > 0.05 and their variance were also 
homogen with p > 0.05. All pretest data were comparable (p > 0.05), therefore, the mean 
different of various treatment of fish oil can be only performed based on posttest data and  
analyzed using one way anova. It was obtained that there are diffirent between all treatment. 
Then, followed by Post Hoc test (LSD) to determine the different. The Post Hoc Test results 
were presented on Table 2.                        Table 2 
Resume of Post Hoc Test of TNF-α Levels 
 
Treatment Mean Different of TNF-α (pg/mL) p* 
SFO 0% (control) - SFO 10%   0.79 0.770 
 - SFO 15%   3.69 0.177 
 - SFO 20% 12.55 0.001 
 - SFO 25%   1.10 0.686 
SFO 10% - SFO 15%   2.90 0.287 
 - SFO 20% 11.76 0.001 
 - SFO 25%   0.30 0.911 
SFO 15% - SFO 20%   8.86 0.002 
 - SFO 25% - 2.59 0.339 
SFO 20% - SFO 25% - 1.45 0.001 
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              SFO = Sardinella longiceps fish oil    
              *significant p < 0.05 
 
 
Decrease of IL-6 Levels  
 Mean of pre and postest data of IL-6 serum levels were presented on Table 3.  
Table 3 
Mean of IL-6 serum levels Data Pre and Posttest 
Treatment IL-6 ( pg/mL) Pretest Postest 
SFO   0% (control) 134.58 ± 2.21 133.15 ± 4.01   
SFO 10 % 134.24 ± 2.64 130.28 ± 3.59  
SFO 15 % 134.75 ± 2.51 127.20 ± 5.56  
SFO 20 % 134.64 ± 1.98 113.87 ± 4.30  
SFO 25 % 135.34 ± 4.57 120.87 ± 7.89  
       SFO = Sardinella longiseps fish oil 
 
 Data on Table 3 were normally distributed with p > 0.05 and their variance were also 
homogen with p > 0.05. The mean different of various fish oil treatment can be performed on the 
basis of posttest data, if, however, all pretest data are comparable. It was obtained that all pretest 
data are comparable with p < 0.05, therefore, mean different of the treatment were obtained 
based on posttest data and analyzed using one way anova. There were significant different of 
treatment obtainedwith p < 0.0 , then the data were analyzed using Post Hoc Test to measured 
the different. Post Hoc test results were sumerized in Table 4.  
Table 4 
Resume of Post Hoc Test of IL-6 Levels 
Treatment Mean Different of IL-6 (ρg/mL) p* 
SFO 0% (control) - SFO 10%   2.87 0.232 
 - SFO 15%   5.95 0.016 
 - SFO 20% 19.28 0.001 
 - SFO 25% 12.28 0.001 
SFO 10% - SFO 15% - 3.09 0.201 
 - SFO 20% 16.41 0.001 
 - SFO 25%   9.41 0.001 
SFO 15% - SFO 20% 13.33 0.001 
 - SFO 25%   6.33 0.011 
SFO 20% - SFO 25% - 7.00 0.001 
               SFO = Sardinella longiceps fish oil 
5 
 






 The research results indicate that the higherst decrease of 12.55 pg/mL of TNF-α was 
obtained for intake of 20% SFO. Increase of SFO to 25% could not increase the decrease of 
TNF-α levels. This condition indicates that concentration of 25% SFO has already saturated, 
therefore, it could not decrease of TNF-α levels any further. This was supported by the finding 
of Chen and Goeddel (2002), they found that there is no transcription of NF-Kβ, so that, no 
further production of TNF-α due to saturation. 
 Inflammation is a response of tissue demage during vascularization. This response is 
followed by an important process, such as endotelial process. Endotel is an important parts of 
blood vein that play an important role in atheroschlerosis. Endotel is a main target of mechanical 
and chemical demage due to dislipidemia risk factor. Chronic, continues, and prolong 
dislipidemia resulted in proinflammation response and prothrombic which are intially acute 
becoming chronic. This will be followed by infiltration of leucocyte cells, mainly, monocyte 
cells to lower subendotelial tissue to form macrophage cells. These cells will destroy all remains 
LDL-C and oxydized to form foam cells and change to ateroma (Baraas, 2006).  
 The last two decades research obtained that fish oil is effective as an anti inflammation. 
This is due to fish oil rich of eicosapentanoic acis (EPA) and dokohexanoic acid (DHA). These 
fatty acids are group as poly unsaturated fatty acid with double bond at the third carbon atom 
(from metil group) which are known as οmega-3 (Han, et al., 2002; Ahmed, 2001; Stefan, et al., 
1996). In this study, sardinella longiceps oil which is rich of omega-3 was applied and proved to 
exeed anti inflammation effect. This anti inflammation effect is due to activation endothelium 
nuclear factor-kapa beta (ENF-κβ) on perifer vein. ENF-κβ is a transcription factor distributed 
on all endotelial cells that have a role in controlling of vascularization.  
 Simopolous (2002) obtained that the role of omega-3 as an anti inflammation is due to 
their action as immunomodulator. In addition, their role as antiinflammation is as a results of 
arachidonic acids effect. These acids are substrate for triggering formation of cyclooxyginase 
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and 5-lipooxyginase. These two oxyginases have vasodilator endothelium-dependent behaviour 
to cause relaxation of ordinary coronary arteri and paradoxal vasoconstruction on 
atheroschlerosis arteri.  
 
 Data in Table 4 indicate that there is a decrease of IL-6 levels since the intake of 10% of 
SFO. Eventhough, there is a decrease of IL-6 levels caused by treatment of 10% SFO which is 
about 2.87 pg/mL, the decrease is not significant statistically with p > 0.05. Then, intake of  15% 
SFO resulted in significantly decrease of  5.95 pg/mL of IL-6 levels with p < 0.05. In addition, 
intake of 20% SFO have also a similar trend to significantly decrease of 19.28 pg/mL of IL-6 
levels with p < 0.05. However, increase of concentration to 25% SFO intake did not significantly 
decrease IL-6 levels, indicates by p > 0.05. 
 Sardinella longiceps oil are rich of eicosapentaenoic acid (EPA) and dokohexanoic acids 
(DHA). These two acids are goruped to omega-3 has an ability as an antiinflammation. During 
endotel cells experiencing of activated inflammation leads to increase selectin and VCAM-1 
expression. VICAM-1 induce monocyte adhesion. This adhesion was also induced by 
proinflammation cytokine, such as 1L-1β and TNF-α. These cytokines were induced by CRP 
protein produced as a results of IL-6 response by protease activated receptor signaling, uptake of 
oxLDL, through oxLDL receptor-1 (LOX-1) and by interaction of CD40/CD40 ligand in arteri 
intima (Bonetti, et al., 2003). IL-6 has an important role in inflammation response and this 
cytokine is secreted by activated-macrophage, leads to phebric and known as pyrogen endogen. 
IL-6 was also initiate phase acute response marked by protein phase acute production by 
hepatocyte (Coico, et al., 2003). 
 
CONCLUSSIONS 
1. Intake of 20% SFO decrease TNF-α serum levels of atheroschlerosis Wistar rat around 
45.63%, i.e. from 28.62±4.72 to 15.56±7.20 рg/mL. 
2. Intake of 20% SFO decrease IL-6 serum levels of atheroschlerosis Wistar rat around 






 The author would like to thanks Prof. Dr. dr. A. A. G. Sudewa Djelantik, Sp.PK; Prof. 
Dr. dr. I Wayan Wita, SpJP; and Prof. Drh. N. Mantik Astawa, Ph.D; for their invaluable 
supervision during doctoral study. Great thanks to Indonesian Government through Higher 
degree of Education and National Education Ministry for funding this research.  
 
REFFERENCES 
Ahmed, E. 2001. Immune Mechanism in Atherosclerosis. Dissertation. ISSBN: 91-628-4612-4. 
Konferensrummet, Centrum för Molekulär Medicin, Karolinska Sjukhuset. 
Baraas-Faisa. 2006. Kardiologi Molekuler Radikal Bebas, Disfungsi Endotel, Aterosklerosis. 
Antioksidan Latihan Fisik dan Rehabilitasi Jantung. Bagian Kardiologi FKUI/ RS 
Jantung Harapan Kita. Jakarta. 
Bonetti, P. O., Lerman, L. O., and Lerman, A. 2003. Endothelial Dysfunction: A Marker of 
Atherosclerosis Risk. Aterisoscler Thromb Vase Biol. 23: p. 168-175. 
Chen, G., and Goeddel, D. V. 2002. TNFR-1 Signaling: A Beautiful Pathway. Science. 296: p. 
1634 – 1635. 
Coico, R., Li, S., J., and Benyamin, E. 2003. Element of innate and acquiered immunity 
Immunology. In:  immunology. A Short Course, 5th ed. New Jersey, John Wiley & Sons 
p: 11 – 26. 
Han, S. N., Leka, L. S., Lichtenstein, A. H., Ausman, L. M., Schaefer, E. J., and Meydani,  S. N. 
2002. Effect of Hydrogenated and Saturated, Relative to Polyunsaturated, Fat on 
Immune and Inflammatory Responses of Adults with Moderate Hypercholesterolemia. 
Journal of Lipid Research. 43(3): p. 445-52. 
Kanjwal, M. 2004. Peripheral Aterial Disease-The Silent Killer.JK-Practitioner, october-
December:1 (no.4):235-232. 
Simopulus, A. P. 2002. Omega-3 Fatty Acids in Inflamation and Autoimmune Diseasess. Journal 
of the American College and Nutrition. 21 (6):  
            p.495-505. 
Stefan, J., Mikko, P. S. A., Bengt, K., and Jan-Nilsson. 1996. Human Monocytes/ Macrophages 
Release TNF-α in Response to Ox-LDL. Arteriosclerosis, Thrombosis, and Vascular 
Biology.16:1573-1579. 
Szmitko, P. E., Wang, C. H., Weisel, R. D., De-Almmeida, J. R., Anderson, T. J., and Verma, S. 
2003. New Markers of Inflammation and Endothelial Cell Activation.Circulation 108: 
1917-1923. 
Vinay, K., Abbas, A. K., and Nelson, F. 2004. Pathologic basic of disease 7 th ed. Elsivier 
saunders.New York. 
 
    
  
